Clearly Comfortable, Reliably Mask-Free
The ProSoft® series of Hi-VNI® nasal cannulas offers a soft, safe, and reliable alternative for a wide patient acuity range.
Unlike commodity high flow oxygen devices (HFNC), Vapotherm® high velocity therapy is FDA cleared for use with respiratory distress patients, including high acuity hypercapnic patients.
Vapotherm’s small bore cannula was designed with high velocity in mind
A smaller diameter cannula increases velocity to more efficiently flush CO2 at lower and more comfortable flows.
A Variety Of Sizes Ensures the Perfect Fit For Your Patients
8 sizes are available from neonate to adult long with 4 inches of added lariat length to improve fit and comfort for larger patients. Each size is clearly color-coded for fast identification. No proprietary adhesive support is required.
| Cannula Sizes | Cannula Flow Range |
|---|---|
| Premature | 1-8 L/min |
| Neonate | 1-8 L/min |
| Infant | 1-8 L/min |
| Intermediate Infant | 1-8 L/min |
| Pediatric Small | 1-20 L/min |
| Pediatric / Adult Small | 5-40 L/min |
| Adult | 5-40 L/min |
| Adult Large | 5-40 L/min |
Color-Coded For Easy Selection
Quickly identify the right cannula for your patient.
Get A
Demo
See why Vapotherm’s nasal cannulas are superior with Precision Flow Plus.
Sales
Inquiry
Get immediate assistance with ordering nasal cannulas or sales-related questions.
Customer
Support
Get in touch with customer support for assistance with nasal cannula fitting and flow selection.
Prosoft Hi-VNI Nasal Cannulas are not available in all markets. Consult your Vapotherm representative for more information.
[1] Gregoretti et al. Evaluation of patient skin breakdown and comfort with a new face mask for non-invasive ventilation: a multi-center study. Inten Care Med 2002; 28:278-284. [2] Black J, Kalowes P. Medical Device-Related Pressure Ulcers. Chronic Wound Care Management and Research Volume 3; 29 August 2016 Volume 2016:3 Pages 91—99. [3] Lukose, Molykutty et al. No More Sore Ears: Nasal Cannula Related Pressure Ulcers Down to Zero. WOCN Society’s 49th Annual Conference, 2017. [4] Doshi, Pratik et al. High-Velocity Nasal Insufflation in the Treatment of Respiratory Failure: A Randomized Clinical Trial. Annals of Emergency Medicine, 2018.